New Proteins for New Medicines, with Help from AI

In this latest installment of Dissertation in One Minute, biophysics PhD candidate Benjamin Fry explains how artificial intelligence is transforming the way scientists design proteins for medicine. By combining AI with computational modeling, his research creates new proteins that can bind to specific ligands—small molecules such as drugs, hormones, and other compounds—with remarkable precision. This breakthrough could accelerate the development of targeted cancer therapies, advanced biosensors, and life-saving antidotes, opening new possibilities for designing medicines tailored to some of today's most challenging health problems.